Butyrate's mechanisms: (1) Colonocyte fuel, enters mitochondria via β-oxidation, providing 70% of colonocyte ATP (healthy colonocytes preferentially use butyrate over glucose); (2) HDAC inhibition, butyrate is a class I/II histone deacetylase inhibitor, altering gene expression toward anti-inflammatory, anti-proliferative, and pro-apoptotic programs (this is the anti-cancer mechanism); (3) GPR41/GPR43/GPR109A receptor activation, these SCFA receptors on immune cells, enteroendocrine cells, and neurons mediate immune tolerance (Treg induction), GLP-1/PYY secretion (satiety), and gut-brain signaling; (4) tight junction protein upregulation, increases expression of claudins and occludin, strengthening the intestinal barrier; (5) mucosal blood flow increase, vasodilatory effects in colonic vasculature.
No critical interactions identified.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.